Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true Include NPL false

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61B AND EN_ALLTXT:(coronavirus OR coronaviruses OR coronaviridae OR coronavirinae OR orthocoronavirus OR orthocoronaviruses OR orthocoronaviridae OR orthocoronavirinae OR betacoronavirus OR betacoronaviruses OR betacoronaviridae OR betacoronavirinae OR sarbecovirus OR sarbecoviruses OR sarbecoviridae OR sarbecovirinae OR "severe acute respiratory syndrome" OR sars OR "2019 ncov" OR covid)

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.2020102382AN ARTIFICIAL INTELLIGENCE BASED SYSTEM FOR COVID PREVENTION
AU 08.10.2020
Int.Class G16H 50/20
GPHYSICS
16INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
50ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
20for computer-aided diagnosis, e.g. based on medical expert systems
Appl.No 2020102382 Applicant Bhasin, Narinder Kumar DR Inventor
The present invention relates to an artificial intelligence based system for COVID prevention. The proposed invention incorporates a definite number of subsystems each enabling checks and/or preventive actions against the most obvious symptoms of coronavirus. The invention has to be deployed at the entry point of the place of human assembly restricts the virus-infected people from entering the premise
2.10888283COVID-19 symptoms alert machine (CSAM) scanners
US 12.01.2021
Int.Class A61B 5/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
Appl.No 16917896 Applicant Boonsieng Benjauthrit Inventor Boonsieng Benjauthrit

A COVID-19 Symptoms Alert Machine (CSAM) scanner, or apparatus, is described herein. This apparatus employs Artificial Intelligent (AI) technology in combination with the latest mobile device technology (viz. smart phone/smart watch) to quickly help track down people who have COVID-19 symptoms anywhere and anytime, isolate them, and professionally handle them, not allowing SARS-CoV-2 virus to spread. CSAM automatically measures body temperature and assesses lung conditions such as pulmonary fibrosis and B-lines (for asymptomatic people), and other current health vital information (CHVI), furnished by the participant, such as fever, sore throat, headache, and body ache to generate an alert signal when COVID-19 symptoms are found significant and to send it out to a COVID-19 control center. The alerted participant is then immediately required to go to the COVID-19 control center or be picked up by a special COVID-19 emergency vehicle for isolation and further evaluation and testing. If the testing turns out to be COVID-19 positive, the participant will be quarantined and treated appropriately according to COVID-19 protocol until he/she is tested COVID-19 negative. In the meantime, people who have been in close physical contact with this participant will be alerted and requested to be immediately checked for COVID-19 symptoms. If anyone is found to have COVID-19 symptoms, then he/she must go through the same protocol. The process is repeated until all people in the cluster are tested COVID-19 negative. This will ensure that SARS-CoV-2 virus for this cluster has been completely eliminated. A rapid deployment of this type of apparatus throughout communities where people tend to congregate such as superstores, supermarkets, and any other establishments, small or large, can help to contain the rapid spread of the disease, as well as to give more confidence to the general public. People, who pass through this apparatus without an alert signal, should feel more confident in carrying out their activities, though social distancing and other COVID-19 precautionary requirements should still be maintained. The concept can be further expanded to cover shopping malls, concert halls, sports arenas, and any other large events including highways and freeways with the help of mobile phone technologies, transponders, and other mobile devices. By working on the 0.6% (around 2 million infected people in the US as of June 2020) quickly and effectively, instead of on the 99.4% (330 million, the remaining population) by locking people at home and closing down all businesses and activities; we can save a significant amount of money and hassles. (A long lockdown can also lead to a collapse of our economy and can consequently lead to a worldwide calamity.) In this way the 99.4% will not be burdened with the virus problem and can live normally without having to take any test. It is probably the only effective approach in solving the COVID-19 problem at the moment because vaccines and known COVID-19 cures are not yet available. Even if SARS-CoV-2 vaccines are available presently, they may not be practical to implement economically and operationally in time to contain the virus worldwide due to the massive amount of people (viz. over 7 billion).

3.2020102250AN ARTIFICIAL INTELLIGENCE AND IOT BASED COVID-19 EARLY WARNING SYSTEM FOR SENIOR CITIZENS
AU 01.10.2020
Int.Class A61B 5/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
Appl.No 2020102250 Applicant Babu, G. Venkata Suresh DR Inventor
The present invention relates to an artificial intelligence based covid-19 early warning system for senior citizens. In the proposed system, various types of health sensors collect body temperature, heartbeat, respiratory rate, resting pulse oxygen saturation, the partial pressure of oxygen, multiple pulmonary lobes from various body parts of the patients. Then an early warning score (EWS) is derived by comparing the deviation of values with standard benchmark values collected from normal people. If the EWS is high, then an early warning message will be sent as SMS to the respective health care unit along with the details of location, using Wi-Fi module. This Wi-Fi module sends the signals through the IoT technology. Following invention described in detail with the help of figure 1 of sheet 1 which shows block diagram of the proposed system, figure 2 of sheet 2 shows the architecture of the developed system with sensors and communication channels. Figure 1
4.WO/2020/254797TREATMENT OF ACUTE MEDICAL CONDITIONS BY STIMULATING THE NEURAL ACTIVITY OF A NERVE SUPPLYING THE SPLEEN
WO 24.12.2020
Int.Class A61N 1/36
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
1Electrotherapy; Circuits therefor
18Applying electric currents by contact electrodes
32alternating or intermittent currents
36for stimulation, e.g. heart pace-makers
Appl.No PCT/GB2020/051457 Applicant GALVANI BIOELECTRONICS LIMITED Inventor GUPTA, Isha
Electrical stimulation of neural activity in the neural innervation of the spleen that is associated with neurovascular bundles provides a useful way to treat acute medical conditions, such as trauma, hemorrhaging, shock, acute respiratory distress syndrome (ARDS), severe respiratory distress syndrome (SARS), and coronavirus disease 19 (COVID-19).
5.20100136513Assay for sars coronavirus by amplification and detection of nucleocapsid rna sequence
US 03.06.2010
Int.Class C12Q 1/70
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
70involving virus or bacteriophage
Appl.No 10570781 Applicant LOU JIANRONG Inventor Lou Jianrong

Primers and probes derived from SARS-CoV nucleic acid that facilitate detection and/or quantification of the nucleocapsid gene are disclosed. The disclosed sequences may be used in a variety of amplification and non-amplification formats for detection of SARSCoV infection.

6.20080044816Assay for SARS coronavirus by amplification and detection of the replicase sequence
US 21.02.2008
Int.Class C12Q 1/68
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
68involving nucleic acids
Appl.No 10570704 Applicant Becton, Dickinson and Company Inventor Lou Jianrong

Primers and probes derived from SARS-CoV nucleic acid that facilitate detection and/or quantification of the replicase gene are disclosed. The disclosed sequences may be used in a variety of amplification and non-amplification formats for detection of SARS-CoV infection.

7.20090258340Assay for SARS coronavirus by amplification and detection of the replicase sequence
US 15.10.2009
Int.Class C12Q 1/68
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
68involving nucleic acids
Appl.No 12322520 Applicant Becton, Dickinson and Company Inventor Lou Jianrong

Primers and probes derived from SARS-CoV nucleic acid that facilitate detection and/or quantification of the replicase gene are disclosed. The disclosed sequences may be used in a variety of amplification and non-amplification formats for detection of SARS-CoV infection.

8.2020101336AN EFFICIENT MACHINE LEARNING TECHNIQUE TO TRACK THE COVID PATIENTS ALONG WITH SECONDARY CONTACTS
AU 30.07.2020
Int.Class G16H 10/60
GPHYSICS
16INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
10ICT specially adapted for the handling or processing of patient-related medical or healthcare data
60for patient-specific data, e.g. for electronic patient records
Appl.No 2020101336 Applicant D, SAISANTHIYA MRS Inventor
An efficient machine learning technique to track the COVID patients along with Primary and secondary contact lists is the proposed invention, which plays a vital role to avoid the spread of this highly contagious disease. Pandemics are bane to the world which will affect the economy and life style of the citizens of any country that is affected. Thus there is a need to automate the process of tracking down the contact list of the COVID patient and monitor the quarantined person 24*7 to check whether the person is violating the isolation rules or not. The invention aims at implementing machine learning and artificial intelligence techniques to statistically analyze the case studies and arriving at conclusions in fraction of time.
9.2020102228A SYSTEM FOR DETECTION OF CORONA VIRUS IN HUMAN BODY USING ARTIFICIAL INTELLIGENCE
AU 01.10.2020
Int.Class G16H 50/80
GPHYSICS
16INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
50ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
80for detecting, monitoring or modelling epidemics or pandemics, e.g. flu
Appl.No 2020102228 Applicant Agrawal, Pankaj DR Inventor
The present invention relates to a system for detection of corona virus in human body using artificial intelligence. The proposed can detect likelihood of the Covid-19, measure oxygen saturation and temperature of the patient. Invented system comprises a testing stand which having stethoscopes connected to a microphone to listen and record the respiratory sounds of the patient, a pulse oximeter to measure the oxygen saturation level of the patient, an IR temperature sensor to measure the temperature of the patient and a computer which comprises of a machine learning software to combine and analyse all readings to produce the final result. Following invention described in detail with the help of figure 1A of sheet 1 shows covid-19 diagnostic system with a patient, figure 1B of sheet 1 shows expanded view of covid-19 diagnostic system. Figure 1A
10.WO/2021/062378IN VIVO AND POINT-OF-CARE SAMPLE CAPTURE AND TESTING SYSTEMS
WO 01.04.2021
Int.Class G01N 33/543
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
543with an insoluble carrier for immobilising immunochemicals
Appl.No PCT/US2020/053103 Applicant BARNETT, Brad Inventor BARNETT, Brad
A sample capture and testing system can include a primary receptacle for receiving a fluid sample, where the primary receptacle has a sensor for label-free detection of an analyte disposed at one side. The primary receptacle can be incorporated in a needle for in vivo capture and testing of a sample. The primary receptacle can be incorporated into a specimen container and used as part of a point of care device.